TGFBR2 and glioblastoma: To test this hypothesis, we used two independent shRNAs (Fig. 3a, b) and ITD131 (Fig. 3c, d), a specific TGFBR2 small-molecule inhibitor, to block TGFBR2 signaling in GBM neurospheres.